These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8401379)

  • 1. The use of [18F]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: model alkylation studies and its application in the design of dopamine D1 and D2 receptor-based imaging agents.
    Mach RH; Elder ST; Morton TE; Nowak PA; Evora PH; Scripko JG; Luedtke RR; Unsworth CD; Filtz T; Rao AV
    Nucl Med Biol; 1993 Aug; 20(6):777-94. PubMed ID: 8401379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography.
    Mach RH; Luedtke RR; Unsworth CD; Boundy VA; Nowak PA; Scripko JG; Elder ST; Jackson JR; Hoffman PL; Evora PH
    J Med Chem; 1993 Nov; 36(23):3707-20. PubMed ID: 8246241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-18 labelled substituted benzazepines as potential radiotracers for imaging dopamine D1 receptors by positron emission tomography.
    Mukherjee J; Yang ZY; Perry BD
    Eur J Pharmacol; 1993 Oct; 243(3):287-90. PubMed ID: 8276082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
    Halldin C; Högberg T; Farde L
    Nucl Med Biol; 1994 May; 21(4):627-31. PubMed ID: 9234320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
    Mach RH; Nader MA; Ehrenkaufer RL; Line SW; Smith CR; Luedtke RR; Kung MP; Kung HF; Lyons D; Morton TE
    Synapse; 1996 Dec; 24(4):322-33. PubMed ID: 10638823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and preliminary biological evaluation of [18F]NCQ-115: a new selective reversible dopamine D2 receptor ligand.
    Najafi A; Peterson A; Buchsbaum M; O'Dell S; Weihmuller F
    Nucl Med Biol; 1993 May; 20(4):549-55. PubMed ID: 8504293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
    Moerlein SM; Perlmutter JS; Welch MJ
    Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum.
    Berendse HW; Richfield EK
    Neurosci Lett; 1993 Feb; 150(1):75-9. PubMed ID: 8097026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain.
    Mach RH; Ehrenkaufer RL; Greenberg JH; Shao L; Morton TE; Evora PH; Nowak PA; Luedtke RR; Cohen D; Reivich M
    Synapse; 1995 Mar; 19(3):177-87. PubMed ID: 7784958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine.
    Ding YS; Logan J; Bermel R; Garza V; Rice O; Fowler JS; Volkow ND
    J Neurochem; 2000 Apr; 74(4):1514-21. PubMed ID: 10737608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2- and 4-[18F]fluorotropapride, two specific D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies.
    Damhaut P; Cantineau R; Lemaire C; Plenevaux A; Christiaens L; Guillaume M
    Int J Rad Appl Instrum A; 1992 Oct; 43(10):1265-74. PubMed ID: 1330979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.
    Gifford AN; Park MH; Kash TL; Herman LM; Park EH; Gatley SJ; Volkow ND
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):413-8. PubMed ID: 11111836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
    Chumpradit S; Kung MP; Billings J; Mach R; Kung HF
    J Med Chem; 1993 Jan; 36(2):221-8. PubMed ID: 8093734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.
    Wong AC; Shetreat ME; Clarke JO; Rayport S
    Neuroscience; 1999 Mar; 89(1):221-33. PubMed ID: 10051231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological investigations of [18F]MR18445, a 5-HT3 receptor partial agonist.
    Katounina T; Besret L; Dhilly M; Petit-Taboué MC; Barbelivien A; Baron JC; Dauphin F; Barré L
    Bioorg Med Chem; 1998 Jun; 6(6):789-95. PubMed ID: 9681144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligands.
    Kiesewetter DO; Kawai R; Chelliah M; Owens E; McLellan C; Blasberg RG
    Int J Rad Appl Instrum B; 1990; 17(4):347-56. PubMed ID: 2143753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated tracers for the evaluation of dopamine receptors in the neonatal rat brain after hypoxic-ischemic injury.
    Zouakia A; Chalon S; Kung HF; Dognon AM; Saliba E; Besnard JC; Guilloteau D
    Eur J Nucl Med; 1994 Jun; 21(6):488-92. PubMed ID: 8082661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates.
    Elwan MA; Soliman MR
    Pharmacology; 1995 Aug; 51(2):73-83. PubMed ID: 8584575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.